Giardiasis, as an alternative or adjunct to metronidazole, especially in children
Microsporidiosis, including ocular microsporidiosis caused by Encephalitozoon hellem or E. cuniculi, when combined with topical fumagillin
Granulomatous amoebic encephalitis, when caused by the ameba Balamuthia mandrillaris, in combination with miltefosine and fluconazole
Arthropods
Crusted scabies, when combined with topical crotamiton and salicylic acid
Head lice infestation, though ivermectin is much better
Intestinal myiasisThough albendazole is effective in treating many diseases, it is only FDA-approved for treating hydatid disease caused by dog tapeworm larvae and neurocysticercosis caused by pork tapeworm larvae. Pregnancy
Albendazole is a pregnancy class D drug in Australia and pregnancy class C in the United States. It is contraindicated in the first trimester of pregnancy, and should be avoided up to one month before conception. While studies in pregnant rats and rabbits have shown albendazole to be teratogenic, albendazole has been found to be safe in humans during the second and third trimesters. It can, however, possibly cause infantile eczema when given during pregnancy.In pregnant dogs, albendazole use has led to puppies with reduced weight and with cleft palates. Birds have lower rates of laying eggs and hatching when given albendazole.Albendazole sulfoxide is secreted into breast milk at around 1.5% of the maternal dose, though oral absorption is poor enough that it is unlikely to affect nursing infants. Contraindications
Hypersensitivity to the benzimidazole class of compounds contraindicates its use. Side effects
The most common side effects by albendazole are experienced by over 10% of people and include headache and abnormal liver function.
See also
List of MeSH codes (C19)
List of ICD-9 codes 240-279: Endocrine, nutritional and metabolic diseases, and immunity disorders

References
External links

Endocrine+system+diseases at the US National Library of Medicine Medical Subject Headings (MeSH)
MedlinePlus Overview endocrinediseases